Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: results from the FACE-BD cohort

View ORCID ProfileN Vidal, View ORCID ProfileE Brunet-Gouet, View ORCID ProfileS Frileux, B Aouizerate, View ORCID ProfileV Aubin, View ORCID ProfileR Belzeaux, View ORCID ProfileP Courtet, View ORCID ProfileT D’Amato, C Dubertret, View ORCID ProfileB Etain, View ORCID ProfileE Haffen, D Januel, View ORCID ProfileM Leboyer, A Lefrere, View ORCID ProfilePM Llorca, E Marlinge, E Olié, M Polosan, View ORCID ProfileR Schwan, View ORCID ProfileM Walter, the FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders) group, C Passerieux, View ORCID ProfileP Roux
doi: https://doi.org/10.1101/2023.04.10.23288347
N Vidal
aFondation FondaMental, Créteil, France
bCentre Hospitalier de Versailles, Service Hospitalo-Universitaire de Psychiatrie d’Adultes et d’Addictologie, Le Chesnay; Université Paris-Saclay; Université de Versailles Saint-Quentin-En-Yvelines; DisAP-DevPsy-CESP, INSERM UMR1018, Villejuif, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for N Vidal
  • For correspondence: nathan.vidal{at}ens-paris-saclay.fr
E Brunet-Gouet
aFondation FondaMental, Créteil, France
bCentre Hospitalier de Versailles, Service Hospitalo-Universitaire de Psychiatrie d’Adultes et d’Addictologie, Le Chesnay; Université Paris-Saclay; Université de Versailles Saint-Quentin-En-Yvelines; DisAP-DevPsy-CESP, INSERM UMR1018, Villejuif, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E Brunet-Gouet
S Frileux
aFondation FondaMental, Créteil, France
bCentre Hospitalier de Versailles, Service Hospitalo-Universitaire de Psychiatrie d’Adultes et d’Addictologie, Le Chesnay; Université Paris-Saclay; Université de Versailles Saint-Quentin-En-Yvelines; DisAP-DevPsy-CESP, INSERM UMR1018, Villejuif, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S Frileux
B Aouizerate
aFondation FondaMental, Créteil, France
cCentre Hospitalier Charles Perrens, Laboratoire NutriNeuro (UMR INRA 1286), Université de Bordeaux, Bordeaux, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V Aubin
aFondation FondaMental, Créteil, France
dPôle de Psychiatrie, Centre Hospitalier Princesse Grace, Monaco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for V Aubin
R Belzeaux
aFondation FondaMental, Créteil, France
ePôle universitaire de psychiatrie>e Pôle universitaire de psychiatrie, CHU deMontpellier, Montpellier, France INT-UMR7289, CNRS Aix-Marseille Université, Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R Belzeaux
P Courtet
aFondation FondaMental, Créteil, France
fCHU Montpellier, Hôpital Lapeyronie, Psychiatric Emergency and Post Emergency Department, Pole Urgence; IGF, Université de Montpellier, CNRS, INSERM, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P Courtet
T D’Amato
aFondation FondaMental, Créteil, France
gUniversity Lyon 1, Villeurbanne; INSERM, U1028; CNRS, UMR5292; Lyon Neuroscience Research Center, Psychiatric Disorders: From Resistance to Response Team, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for T D’Amato
C Dubertret
aFondation FondaMental, Créteil, France
hAP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT, Service de Psychiatrie et Addictologie, Hôpital Louis Mourier, Colombes, France; Université de Paris, Inserm UMR1266, SorbonneParis Cité, Faculté de Médecine, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B Etain
aFondation FondaMental, Créteil, France
iAssistance publique des Hôpitaux deParis, Groupe Hospitalo-universitaire AP-HP Nord, DMU Neurosciences, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN;Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for B Etain
E Haffen
aFondation FondaMental, Créteil, France
jService de Psychiatrie de l’Adulte, CIC-1431 INSERM, CHU deBesançon, Laboratoire de Neurosciences, UFC, UBFC, Besançon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E Haffen
D Januel
aFondation FondaMental, Créteil, France
kUnité de Recherche Clinique, EPS Ville-Evrard, 93332 Neuilly-sur-Marne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Leboyer
aFondation FondaMental, Créteil, France
lUnivParis Est Créteil, INSERM U955, IMRB, Translational NeuroPsychiatry Laboratory,; AP-HP, Hôpitaux Universitaires Henri Mondor, Département Médico-Universitaire de Psychiatrie et d’Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Créteil, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M Leboyer
A Lefrere
aFondation FondaMental, Créteil, France
mPôle de Psychiatrie, Assistance Publique Hôpitaux deMarseille, Marseille, France INT-UMR7289, CNRS Aix-Marseille Université, Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PM Llorca
aFondation FondaMental, Créteil, France
nCentre Hospitalier et Universitaire, Département de Psychiatrie; Université d’Auvergne,; EA 7280, Clermont-Ferrand, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for PM Llorca
E Marlinge
aFondation FondaMental, Créteil, France
iAssistance publique des Hôpitaux deParis, Groupe Hospitalo-universitaire AP-HP Nord, DMU Neurosciences, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN;Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Olié
aFondation FondaMental, Créteil, France
fCHU Montpellier, Hôpital Lapeyronie, Psychiatric Emergency and Post Emergency Department, Pole Urgence; IGF, Université de Montpellier, CNRS, INSERM, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Polosan
aFondation FondaMental, Créteil, France
oUniv. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Schwan
aFondation FondaMental, Créteil, France
pUniversité de Lorraine, Centre Psychothérapique de Nancy, Inserm U1254, Nancy, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R Schwan
M Walter
aFondation FondaMental, Créteil, France
qService Hospitalo-Universitaire de Psychiatrie Générale et de Réhabilitation Psycho Sociale 29G01 et 29G02, CHRU de Brest, Hôpital de Bohars, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M Walter
C Passerieux
aFondation FondaMental, Créteil, France
bCentre Hospitalier de Versailles, Service Hospitalo-Universitaire de Psychiatrie d’Adultes et d’Addictologie, Le Chesnay; Université Paris-Saclay; Université de Versailles Saint-Quentin-En-Yvelines; DisAP-DevPsy-CESP, INSERM UMR1018, Villejuif, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Roux
aFondation FondaMental, Créteil, France
bCentre Hospitalier de Versailles, Service Hospitalo-Universitaire de Psychiatrie d’Adultes et d’Addictologie, Le Chesnay; Université Paris-Saclay; Université de Versailles Saint-Quentin-En-Yvelines; DisAP-DevPsy-CESP, INSERM UMR1018, Villejuif, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P Roux
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Bipolar disorders (BD) are characterized by cognitive impairment during the euthymic phase, to which treatments can contribute. The anticholinergic properties of medications, i.e., the ability of a treatment to inhibit cholinergic receptors, are associated with cognitive impairment in elderly patients and people with schizophrenia but this association has not been well characterized in individuals with remitted bipolar disorders. Moreover, the validity of anticholinergic burden scales designed to assess the anticholinergic load of medications has been scarcely tested in bipolar disorders. We aimed to test the concurrent validity of several scales by assessing their associations with objective cognitive impairment and subjective anticholinergic side-effects in BD. We hypothesized that the scale is valid if its association with cognitive impairment or self-reported anticholinergic side-effects is significant. A sample of 2,031 individuals with euthymic bipolar disorders was evaluated with a neuropsychological battery to identify cognitive impairment. Two scales among 27 were significantly positively associated with cognitive impairment in multiple logistic regressions, whereas chlorpromazine equivalents, lorazepam equivalents, the number of antipsychotics, or the number of treatments were not. The two scales significantly correlated with worse performance in processing speed and verbal memory. In addition, 14 scales showed good concurrent validity to assess self-reported peripheral anticholinergic side-effects and 13 were valid for evaluating self-reported central anticholinergic side-effects. Thus, we identified valid scales to monitor the anticholinergic burden in BD, which may be useful in assessing iatrogenic cognitive impairment in studies investigating cognition in BD.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by a grant from the Centre Hospitalier de Versailles (Bourse Registre 2019), the Fondation FondaMental, Creteil, France, and the Investissements d'Avenir Programs managed by the ANR under references ANR-11-IDEX-0004-02 and ANR-10-COHO-10-01.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Comite de Protection des Personnes - Ile de France IX gave ethical approval for this work (refered documents are available upon request).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted April 17, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: results from the FACE-BD cohort
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: results from the FACE-BD cohort
N Vidal, E Brunet-Gouet, S Frileux, B Aouizerate, V Aubin, R Belzeaux, P Courtet, T D’Amato, C Dubertret, B Etain, E Haffen, D Januel, M Leboyer, A Lefrere, PM Llorca, E Marlinge, E Olié, M Polosan, R Schwan, M Walter, the FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders) group, C Passerieux, P Roux
medRxiv 2023.04.10.23288347; doi: https://doi.org/10.1101/2023.04.10.23288347
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: results from the FACE-BD cohort
N Vidal, E Brunet-Gouet, S Frileux, B Aouizerate, V Aubin, R Belzeaux, P Courtet, T D’Amato, C Dubertret, B Etain, E Haffen, D Januel, M Leboyer, A Lefrere, PM Llorca, E Marlinge, E Olié, M Polosan, R Schwan, M Walter, the FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders) group, C Passerieux, P Roux
medRxiv 2023.04.10.23288347; doi: https://doi.org/10.1101/2023.04.10.23288347

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)